- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report studies the Biosimilar Testing and Development Services market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilar Testing and Development Services market by product type and applications/end industries.
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
The global Biosimilar Testing and Development Services market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biosimilar Testing and Development Services.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Market Segment by Applications, can be divided into
PK assay
Tiered Immunogenicity testing
NAb assays
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biosimilar Testing and Development Services Market Overview
1.1 Product Overview and Scope of Biosimilar Testing and Development Services
1.2 Classification of Biosimilar Testing and Development Services by Types
1.2.1 Global Biosimilar Testing and Development Services Revenue Comparison by Types (2017-2023)
1.2.2 Global Biosimilar Testing and Development Services Revenue Market Share by Types in 2017
1.2.3 Effector Binding
1.2.4 ELISA
1.2.5 Kinetic Binding Assays
1.2.6 ADCC & CDC Cell-Based Assays
1.3 Global Biosimilar Testing and Development Services Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Global Biosimilar Testing and Development Services Market by Regions
1.4.1 Global Biosimilar Testing and Development Services Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biosimilar Testing and Development Services Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biosimilar Testing and Development Services Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilar Testing and Development Services Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biosimilar Testing and Development Services Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilar Testing and Development Services Status and Prospect (2013-2023)
1.5 Global Market Size of Biosimilar Testing and Development Services (2013-2023)
2 Manufacturers Profiles
2.1 Eurofins Scientific
2.1.1 Business Overview
2.1.2 Biosimilar Testing and Development Services Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eurofins Scientific Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.2 SGS
2.2.1 Business Overview
2.2.2 Biosimilar Testing and Development Services Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 SGS Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.3 Charles River Laboratories
2.3.1 Business Overview
2.3.2 Biosimilar Testing and Development Services Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Charles River Laboratories Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pharmaceutical Product Development
2.4.1 Business Overview
2.4.2 Biosimilar Testing and Development Services Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.5 Exova
2.5.1 Business Overview
2.5.2 Biosimilar Testing and Development Services Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Exova Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.6 Source BioScience
2.6.1 Business Overview
2.6.2 Biosimilar Testing and Development Services Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Source BioScience Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.7 Intertek Group
2.7.1 Business Overview
2.7.2 Biosimilar Testing and Development Services Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Intertek Group Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medistri
2.8.1 Business Overview
2.8.2 Biosimilar Testing and Development Services Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medistri Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pace Analytical Services
2.9.1 Business Overview
2.9.2 Biosimilar Testing and Development Services Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pace Analytical Services Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sigma-Aldrich
2.10.1 Business Overview
2.10.2 Biosimilar Testing and Development Services Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimilar Testing and Development Services Market Competition, by Players
3.1 Global Biosimilar Testing and Development Services Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimilar Testing and Development Services Players Market Share
3.2.2 Top 10 Biosimilar Testing and Development Services Players Market Share
3.3 Market Competition Trend
4 Global Biosimilar Testing and Development Services Market Size by Regions
4.1 Global Biosimilar Testing and Development Services Revenue and Market Share by Regions
4.2 North America Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
5 North America Biosimilar Testing and Development Services Revenue by Countries
5.1 North America Biosimilar Testing and Development Services Revenue by Countries (2013-2018)
5.2 USA Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
5.3 Canada Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
5.4 Mexico Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
6 Europe Biosimilar Testing and Development Services Revenue by Countries
6.1 Europe Biosimilar Testing and Development Services Revenue by Countries (2013-2018)
6.2 Germany Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
6.3 UK Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
6.4 France Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
6.5 Russia Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
6.6 Italy Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biosimilar Testing and Development Services Revenue by Countries
7.1 Asia-Pacific Biosimilar Testing and Development Services Revenue by Countries (2013-2018)
7.2 China Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
7.3 Japan Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
7.4 Korea Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
7.5 India Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
8 South America Biosimilar Testing and Development Services Revenue by Countries
8.1 South America Biosimilar Testing and Development Services Revenue by Countries (2013-2018)
8.2 Brazil Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
8.3 Argentina Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
8.4 Colombia Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biosimilar Testing and Development Services by Countries
9.1 Middle East and Africa Biosimilar Testing and Development Services Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
9.3 UAE Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
9.4 Egypt Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
9.6 South Africa Biosimilar Testing and Development Services Revenue and Growth Rate (2013-2018)
10 Global Biosimilar Testing and Development Services Market Segment by Type
10.1 Global Biosimilar Testing and Development Services Revenue and Market Share by Type (2013-2018)
10.2 Global Biosimilar Testing and Development Services Market Forecast by Type (2018-2023)
10.3 Effector Binding Revenue Growth Rate (2013-2023)
10.4 ELISA Revenue Growth Rate (2013-2023)
10.5 Kinetic Binding Assays Revenue Growth Rate (2013-2023)
10.6 ADCC & CDC Cell-Based Assays Revenue Growth Rate (2013-2023)
11 Global Biosimilar Testing and Development Services Market Segment by Application
11.1 Global Biosimilar Testing and Development Services Revenue Market Share by Application (2013-2018)
11.2 Biosimilar Testing and Development Services Market Forecast by Application (2018-2023)
11.3 PK assay Revenue Growth (2013-2018)
11.4 Tiered Immunogenicity testing Revenue Growth (2013-2018)
11.5 NAb assays Revenue Growth (2013-2018)
12 Global Biosimilar Testing and Development Services Market Size Forecast (2018-2023)
12.1 Global Biosimilar Testing and Development Services Market Size Forecast (2018-2023)
12.2 Global Biosimilar Testing and Development Services Market Forecast by Regions (2018-2023)
12.3 North America Biosimilar Testing and Development Services Revenue Market Forecast (2018-2023)
12.4 Europe Biosimilar Testing and Development Services Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biosimilar Testing and Development Services Revenue Market Forecast (2018-2023)
12.6 South America Biosimilar Testing and Development Services Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biosimilar Testing and Development Services Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biosimilar Testing and Development Services Picture
Table Product Specifications of Biosimilar Testing and Development Services
Table Global Biosimilar Testing and D
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
